Month: February 2024

Protocol for a randomized, placebo-controlled, double-blind phase IIa study of the safety, tolerability, and symptomatic efficacy of the ROCK-inhibitor Fasudil in patients with Parkinson’s disease (ROCK-PD)

BackgroundThe Rho-kinase (ROCK) inhibitor Fasudil has shown symptomatic and disease-modifying effects in Parkinson’s disease (PD) models in vitro and in vivo. In Japan, Fasudil has been approved for the treatment of subarachnoid haemorrhage since 1995 and shows a favourable safety profile.Objectives/designTo investigate the safety, tolerability, and symptomatic efficacy of ROCK-inhibitor Fasudil in comparison to placebo […]

Published on February 14, 2024

Hot Flashes, Migraine Combo Spikes Heart Risks

As if painful migraines, hot flashes and night sweats weren’t bad enough, many women in menopause are facing a significantly bigger threat. New research suggests that women with both migraines and vasomotor symptoms (hot flashes and night sweats) are significantly more… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on February 14, 2024

Sugar-reduced chocolate with oat flour just as tasty as original, study finds

The secret to making delicious chocolate with less added sugar is oat flour, according to a new study. In a blind taste test, 25% reduced-sugar chocolates made with oat flour were rated equally, and in some cases preferred, to regular chocolate. The findings provide a new option for decreasing chocolate’s sugar content while maintaining its […]

Published on February 14, 2024